Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07201298 · ClinicalTrials.gov registry record · NA
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
A NA study of Myopia and Astigmatism, sponsored by Hoopes Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07201298: Recruiting NA study of Myopia and Astigmatism, sponsored by Hoopes Vision.
NCT07201298 is a NA study of Myopia and Astigmatism that is actively recruiting participants, run by Hoopes Vision. The registered enrollment target is 120 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07201298, a NA study of Myopia and Astigmatism, is actively recruiting participants, sponsored by Hoopes Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This purpose of this study is to compare a new form of LASIK called Ray Tracing Guided LASIK to 3 other forms of corneal refractive surgery: 1. KLEx (KeratoLenticule Extraction) using the Zeiss Visumax 800 Laser, 2. WFO LASIK (Wavefront Optimized LASIK) using the Alcon EX500 Laser, and 3. Topography Guided LASIK (Contoura LASIK) also using the Alcon EX500 Laser.
Primary Outcome
Percentage of eyes acheiving uncorrected visual acuity of 20/40, 20/25, 20/20, 20/16, 20/12.5, and 20/10 at post-operative month 3, 6 and 12
Conditions Studied
Interventions
- DEVICE Ray-Tracing Guided LASIK
- DEVICE Keratorefractive Lenticule Extraction (KLEx)
- DEVICE WaveFront Optimized LASIK
- DEVICE Topography Guided LASIK
Study Locations (1)
Utah
- Hoopes Moshirfar Research Center - Draper
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09 |
| Est. Completion | 2029-09 |
| Phase | NA |
What NCT07201298 shows while recruiting
NCT07201298 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 4 interventions - of which Ray-Tracing Guided LASIK is the first listed.
NCT07201298 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07201298 about?
NCT07201298 is a clinical study titled "A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism". This purpose of this study is to compare a new form of LASIK called Ray Tracing Guided LASIK to 3 other forms of corneal refractive surgery: 1. KLEx (KeratoLenticule Extraction) using the Zeiss Visumax 800 Laser, 2. WFO LASIK (Wavefront Optimized LASIK) using the Alcon EX500 Laser, and 3. Topography...
What is the current status of trial NCT07201298?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09. Estimated completion is 2029-09.
What conditions does trial NCT07201298 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT07201298?
The interventions under investigation include: Ray-Tracing Guided LASIK (DEVICE), Keratorefractive Lenticule Extraction (KLEx) (DEVICE), WaveFront Optimized LASIK (DEVICE), Topography Guided LASIK (DEVICE).
Who is sponsoring clinical trial NCT07201298?
This trial is sponsored by Hoopes Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07201298 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07201298's enrollment target sits among peer trials
120 32nd of 90 higher than 58 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia